The goal is comprehensive metabolic health, not just a smaller body
Koutsakos M, Illing PT, Nguyen T, Mifsud NA, Crawford JC, Rizzetto S, et al
Brand-Name FDA-Approved Medications Referenced on altRx altRx's source materials also reference brand-name FDA-approved medications at separate listed price points: Mounjaro: Listed at $1,249 per month per altRx's source materials Ozempic: Listed at $1,149 per month per altRx's source materials Wegovy: Listed at $1,579 per month per altRx's source materials Zepbound: Listed at $1,249 per month per altRx's source materials According to altRx's published trademark notice, Wegovy is FDA-approved for weight loss, and Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss at the discretion of a clinician
There are three medicines approved by the US Food and Drug Administration for AUD, but fewer than 2 per cent of people with the disorder receive treatment with them, Hendershot and his co-authors wrote in their paper, noting few people may know about them and that stigma may pose a barrier to treatment
